On the Bombay Stock Exchange (BSE), Max Healthcare Institute’s stocks went up to Rs 482.50 after the company reported a healthy operational performance in the second quarter of FY23. 

The shares of the private sector healthcare services and its previous high of Rs 472.60 in 2021. In the second quarter of FY23, the company’s stocks reported the highest gross revenue of Rs 1,567 crore, up 9 per cent YoY and 6 per cent QoQ. 

• Vedanta Outlook for the Week (April 22, 2024 – April 26, 2024)
• Tata Steel Outlook for the Week (April 22, 2024 – April 26, 2024)
• PFC Outlook for the Week (April 22, 2024 – April 26, 2024)
• Piramal Enterprises Outlook for the Week (April 22, 2024 – April 26, 2024)
• MANAPPURAM Outlook for the Week (April 22, 2024 – April 26, 2024)

EBITDA of network operating stood at Rs 410 crore compared to Rs 362 crore in the second quarter of FY22 and Rs 370 crore in the first quarter of FY23. Operating EBITDA margin in Q1FY22 improved 100 bps YoY and 110 bps QoQ to 27.7 per cent. 

Profit after tax stood at Rs 511 crore in Q2FY23 compared to Rs 207 crore in Q2FY22. The growth in the second quarter of FY23 revenue and operating EBITDA were driven by higher occupancies and increased ARR in OPD.

Max healthcare is to make significant investments over the next four to five years leading to huge employment opportunities and a multiplier effect on GDP. Also, provided by the government, through its focus on healthcare and Heal in India initiatives, will provide a watershed moment for the industry, the management added.